Odonate Therapeutics, Inc. Patent Applications Pending
7 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-03-17: Application PCTUS2021022770; Invention METHODS OF ADMINISTERING TESETAXEL TO PATIENTS WITH HEPATIC IMPAIRMENT; Applicant ODONATE THERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2021-03-17: Application PCTUS2021022724; Invention METHODS OF ADMINISTERING TESETAXEL WITH CYP3A4 INHIBITORS; Applicant ODONATE THERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2019-09-05: Application PCTUS2019049642; Invention METHODS OF TREATING CNS TUMORS WITH TESETAXEL; Applicant ODONATE THERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2019-08-16: Application 62887888; Invention METHODS OF ADMINISTERING TESETAXEL WITH GLUCOCORTICOIDS THAT ARE CYP3A4 INDUCERS; Applicant Odonate Therapeutics, Inc.; Status Provisional Application Expired.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2021-03-17 | PCTUS2021022770 | METHODS OF ADMINISTERING TESETAXEL TO PATIENTS WITH HEPATIC IMPAIRMENT | ODONATE THERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | KEVIN TANG ADAM KAMLET THOMAS WEI STEW KROLL | United States United States United States United States | ||
| 2021-03-17 | PCTUS2021022724 | METHODS OF ADMINISTERING TESETAXEL WITH CYP3A4 INHIBITORS | ODONATE THERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | STEW KROLL ADAM KAMLET KEVIN TANG THOMAS WEI | United States United States United States United States | ||
| 2019-09-05 | PCTUS2019049642 | METHODS OF TREATING CNS TUMORS WITH TESETAXEL | ODONATE THERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | JOYCE JAMES KEVIN TANG STEW KROLL THOMAS WEI STEVEN PFEIFFER JEFF VACIRCA JOHN G. LEMKEY | United States United States United States United States United States United States United States | ||
| 2019-08-16 | 62887888 | METHODS OF ADMINISTERING TESETAXEL WITH GLUCOCORTICOIDS THAT ARE CYP3A4 INDUCERS | Odonate Therapeutics, Inc. | Provisional Application Expired | Joyce James Kevin Tang Stew Kroll John G. Lemkey Steven Pfeiffer Thomas Wei | United States United States United States United States United States United States | ||
| 2019-02-27 | 62811181 | METHODS OF TREATING CNS TUMORS WITH TESETAXEL | Odonate Therapeutics, Inc. | Provisional Application Expired | Joyce James Kevin Tang Stew Kroll John G. Lemkey Steven Pfeiffer Jeff Vacirca Thomas Wei | United States United States United States United States United States United States United States | ||
| 2018-10-17 | 62746926 | METHODS OF TREATING CNS TUMORS WITH TESETAXEL | Odonate Therapeutics, Inc. | Provisional Application Expired | Joyce James Kevin Tang Stew Kroll John G. Lemkey Steven Pfeiffer Jeff Vacirca Thomas Wei | United States United States United States United States United States United States United States | ||
| 2018-06-01 | PCTUS2018035653 | DOSING SCHEDULE FOR TESETAXEL AND CAPECITABINE | ODONATE THERAPEUTICS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | JEFF VACIRCA STEVEN PFEIFFER KEVIN TANG STEW KROLL JOHN G. LEMKEY THOMAS WEI | United States United States United States United States United States United States |